The World Economic Forum published an analysis this week headlined "Crop protection is at risk. How innovation can help," placing pest and disease management back on the agenda for ministers, input manufacturers, and grower groups heading into a year of heavy policy churn.

The headline frames the issue with two clauses. The first — "crop protection is at risk" — names the problem: a shrinking toolkit of conventional pesticides, rising pest resistance, and tighter residue rules. The second — "how innovation can help" — names the prescription: biologicals, digital application tools, and gene-edited pipelines.

That framing aligns with the WEF's wider food-systems work. The Forum runs the Food Action Alliance, the 100 Million Farmers platform, and a series of regional agriculture summits, all of which position technology adoption as the central lever for food security.

What does "at risk" actually cover?

Crop-protection pressure has stacked up for at least a decade. The EU's hazard-based cut-off criteria have removed or restricted dozens of active ingredients since 2019. EPA decisions on glyphosate, dicamba, and atrazine have moved through court remand since 2023. China's pesticide registration tightening has reshaped active-ingredient supply chains. Resistance pressure on herbicides, fungicides, and insecticides keeps eroding older modes of action.

Input manufacturers have answered with restructured R&D budgets. The major agrochemical companies disclose multi-billion-dollar annual agricultural R&D spending; the share directed at biologicals, digital tools, and gene-edited traits grows each year, though slowly.

Why does the Forum's framing matter?

WEF coverage travels. White papers and op-eds from the Forum routinely shape the vocabulary used by ministers, multilateral agencies, and corporate sustainability officers. When the Forum calls crop protection endangered and innovation the cure, that phrasing tends to migrate into FAO strategy documents, World Bank agricultural lending criteria, and corporate ESG disclosures. Agribusiness executives who arrive unprepared at the wrong side of that vocabulary pay a price in policy access.

What does "innovation" mean in the Forum's playbook?

Three lanes carry most of the load. Biological crop protection — biocontrol agents, biostimulants, and microbial inoculants — promises to replace or supplement synthetic chemistry. Digital tools — variable-rate sprayers, AI-driven weed and disease identification, and drone-based application — reduce per-acre product use. Genetic innovation — CRISPR-edited disease resistance, RNAi-based pest control, and accelerated breeding pipelines — cuts dependence on chemistries facing deregistration or consumer backlash. Each lane targets the same pressure point.

What should growers and input suppliers watch next?

For input manufacturers, the operative questions are pipeline depth and time-to-market. Watch 2025 EPA registration-review decisions and the next round of product launches for evidence the innovation pivot is real, not rhetorical.

For cooperatives and retailers, the question is grower willingness to pay. Biological products typically run higher per-acre than conventional chemistry in their first commercial years; whether that gap narrows depends on formulation scale, registration cost, and generic entry into the biological category.

For growers, the calculation is direct. Any new tool that holds back resistance or replaces a deregistered active ingredient carries measurable value. The agronomic learning curve and the risk of a yield drag in the transition year remain real costs. Extension trials in the U.S. Midwest and Great Plains are now comparing biological-plus-conventional programs against conventional-only rotations, with results due at winter county meetings.

The throughline

The Forum's crop-protection coverage typically clusters around its January Davos meeting and its regional summits through the year. Readers should expect companion pieces on biologicals regulation harmonization and on the financing gap for early-stage crop-protection startups. For agribusiness decision-makers, the message is consistent: innovation is now the Forum's preferred answer, and the rest of the policy apparatus is moving in that direction.